HALT-C Trial NIH Program Announcements

HALT-C Ancillary Studies Announcement

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites investigator-initiated research project applications for ancillary studies to ongoing large-scale clinical trials, epidemiological studies and disease databases supported by the Institute. Please see the NIDDK program announcement pages for more information.

HALT-C Trial Ancillary Studies Procedures

• Ancillary Studies Procedures and Policies (PDF Format)
• Ancillary Studies Procedures and Policies (HTML)
• Collborating with HALT-C

Collaboration with the NCI Early Detection Research Network

NIDDK in collaboration with National Cancer Institute through its Early Detection Research Network announces the availability of serum samples and research support for validation of Hepatocellular Carcinoma (HCC) biomarkers among study participants in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis (HALT-C) trial. (NOT-DK-08-014). Click for the Notice. Click for more information on applying (PDF document).